EAST
RUTHERFORD, N.J., July 8, 2024
/CNW/ -- Cambrex today announced the expansion of its stability
storage business, Q1 Scientific, which offers
environmentally-controlled stability storage services to the
pharmaceutical, medical device, and life sciences industries. Q1
Scientific will open a new state-of-the-art facility in
Durham, North Carolina before the
end of 2024, featuring advanced storage capabilities and co-located
next to the existing Cambrex analytical facility.
The new Durham facility will
initially offer 7 ICH stability chambers, covering a range of
conditions including 2-8°C, 25°C/40%RH, 25°C/60%RH, 30°C/65%RH, and
40°C/75%RH, as well as both -20°C and ultra low (-70°C/-80°C)
storage conditions. The phase 2 expansion, planned within the next
24 months, will increase the facility's capacity to 20 chambers,
with the potential for 20,000 cubic feet of storage space when
complete. The facility's Research
Triangle Park (RTP) location in North Carolina will provide same day and next
day delivery across the US.
Tom Loewald, CEO at Cambrex,
stated, "We are thrilled to expand Q1 Scientific's reach into
Durham, North Carolina, enhancing
our ability to serve pharmaceutical companies across North America. This investment not only
broadens our footprint but also leverages Q1 Scientific's extensive
expertise in the stability storage business."
Q1 Scientific's expansion into Durham complements its existing facilities in
Waterford, Ireland, and Liège,
Belgium, giving it a global
footprint with three locations covering both sides of the Atlantic
Ocean.
Stephen Delaney, Managing
Director of Q1 Scientific, added, "Operating three sites globally
will be a significant benefit to our customers, who can now expect
faster turnaround times for the return of samples and greater
temperature-controlled transport options across the US and
Europe."
Cambrex continues to expand its capabilities and capacity across
its North American and European network to meet the growing demand
for outsourced drug development and manufacturing services.
About Cambrex
Cambrex is a leading global contract development and
manufacturing organization (CDMO) that provides drug substance
development and manufacturing across the entire drug lifecycle, as
well as comprehensive analytical and IND enabling services.
With over 40 years of experience and a team of 2,000 experts
servicing global clients from North
America and Europe, Cambrex
offers a range of specialized drug substance technologies and
capabilities, including continuous flow, controlled substances,
solid-state science, material characterization, and highly potent
APIs.
About Q1 Scientific, a Cambrex company
Q1 Scientific, a Cambrex Company, is a leading provider of
environmentally controlled stability storage services for the
pharmaceutical, medical device and life sciences industries. With a
decade of expertise, Q1 Scientific safeguards critical
breakthroughs and life-changing innovations at state-of-the-art
facilities in Ireland and
Belgium. By utilizing Q1
Scientific's services, companies can accelerate the introduction of
new drugs to the market while avoiding the expense of building and
monitoring their own storage chambers. In June 2022, Q1 Scientific was acquired by Cambrex.
Logo -
https://mma.prnewswire.com/media/2236065/Cambrex_logo.jpg
Logo
- https://mma.prnewswire.com/media/1830431/Q1_Scientific_Cambrex_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/cambrex-to-expand-stability-storage-business-with-new-facility-in-durham-north-carolina-302190242.html
SOURCE Cambrex